A Hypoxia-Related Signature for Predicting Prognosis, Cellular Processes, Immune Microenvironment and Targeted Compounds in Lung Squamous Cell Carcinoma.

Wu, Gujie; Zhu, Zhenyu; Yang, Zheng; He, Min; Ren, Kuan; Dong, Yipeng; Xue, Qun

Wu, Gujie; Zhu, Zhenyu; Yang, Zheng; He, Min; Ren, Kuan; Dong, Yipeng; Xue, Qun.

Afiliação

Wu G; Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu, People's Republic of China.
Zhu Z; Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu, People's Republic of China.
Yang Z; Department of Respiratory medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu, People's Republic of China.
He M; Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu, People's Republic of China.
Ren K; Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu, People's Republic of China.
Dong Y; Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu, People's Republic of China.
Xue Q; Department of Cardiothoracic Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu, People's Republic of China.

Int J Gen Med ; 15: 3991-4006, 2022.

Article em En | MEDLINE | ID: mdl-35437352

Palavras-chave

hypoxia; immune; lung squamous cell carcinoma; prognosis; targeted compounds

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Int J Gen Med Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google